Hyloris Pharmaceuticals S.A.
HYL.BR · BRU
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €19 | €19 | €24 | €24 |
| Short-Term Investments | €1 | €1 | €1 | €1 |
| Receivables | €4 | €4 | €5 | €5 |
| Inventory | €0 | €0 | €0 | €0 |
| Other Curr. Assets | €1 | €1 | €1 | €1 |
| Total Curr. Assets | €24 | €24 | €30 | €30 |
| Property Plant & Equip (Net) | €2 | €2 | €2 | €2 |
| Goodwill | €0 | €0 | €0 | €0 |
| Intangibles | €4 | €4 | €4 | €4 |
| Long-Term Investments | €5 | €5 | €4 | €4 |
| Tax Assets | €0 | €0 | €0 | €0 |
| Other NC Assets | €2 | €2 | €2 | €2 |
| Total NC Assets | €13 | €13 | €12 | €12 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €37 | €37 | €41 | €41 |
| Liabilities | – | – | – | – |
| Payables | €2 | €2 | €3 | €3 |
| Short-Term Debt | €0 | €0 | €0 | €0 |
| Tax Payable | €0 | €0 | €0 | €0 |
| Deferred Revenue | €0 | €0 | €0 | €0 |
| Other Curr. Liab. | €4 | €4 | €3 | €3 |
| Total Curr. Liab. | €6 | €6 | €7 | €7 |
| LT Debt | €1 | €1 | €1 | €1 |
| Deferred Rev, NC | €0 | €0 | €0 | €0 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €0 |
| Other NC Liab. | €1 | €1 | €1 | €1 |
| Total NC Liab. | €2 | €2 | €2 | €2 |
| Other Liabilities | €0 | €0 | €0 | €0 |
| Cap. Leases | €2 | €2 | €2 | €2 |
| Total Liabilities | €8 | €8 | €9 | €9 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €0 |
| Common Stock | €0 | €0 | €0 | €0 |
| Retained Earnings | -€90 | -€90 | -€86 | -€86 |
| AOCI | -€3 | -€3 | -€3 | -€3 |
| Other Equity | €122 | €122 | €122 | €122 |
| Total Equity | €29 | €29 | €32 | €32 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €37 | €37 | €41 | €41 |
| Net Debt | -€17 | -€17 | -€22 | -€22 |